{"id": "article-23616_0", "title": "Internal Jugular Vein Thrombosis -- Continuing Education Activity", "content": "Internal jugular vein thrombosis occurs when a thrombus develops in the lumen of the internal jugular vein (IJV). Hereditary and acquired risk factors for thrombosis include intravenous drug use, factor V Leiden mutation, malignancy, hormone replacement therapy, immobilization, trauma, pregnancy, and central line cannulation. One way that interprofessional team members can decrease the incidence of this disorder is by limiting the use of internal jugular vein cannulation both in frequency and duration. Central lines should be removed when no longer needed and when possible, alternative sites should be used for venous access. This activity reviews the etiology, evaluation, and management of IJV thrombosis and highlights the role of the interprofessional team in evaluating, treating and preventing this condition.", "contents": "Internal Jugular Vein Thrombosis -- Continuing Education Activity. Internal jugular vein thrombosis occurs when a thrombus develops in the lumen of the internal jugular vein (IJV). Hereditary and acquired risk factors for thrombosis include intravenous drug use, factor V Leiden mutation, malignancy, hormone replacement therapy, immobilization, trauma, pregnancy, and central line cannulation. One way that interprofessional team members can decrease the incidence of this disorder is by limiting the use of internal jugular vein cannulation both in frequency and duration. Central lines should be removed when no longer needed and when possible, alternative sites should be used for venous access. This activity reviews the etiology, evaluation, and management of IJV thrombosis and highlights the role of the interprofessional team in evaluating, treating and preventing this condition."}
{"id": "article-23616_1", "title": "Internal Jugular Vein Thrombosis -- Continuing Education Activity", "content": "Objectives: Outline the risk factors for internal jugular vein thrombosis. Describe the imaging studies used to evaluate internal jugular vein thrombosis. Summarize the management considerations for internal jugular vein thrombosis. Explain the importance of improving care coordination amongst interprofessional team members to improve the outcomes of patients with internal jugular vein thrombosis thrombosis. Access free multiple choice questions on this topic.", "contents": "Internal Jugular Vein Thrombosis -- Continuing Education Activity. Objectives: Outline the risk factors for internal jugular vein thrombosis. Describe the imaging studies used to evaluate internal jugular vein thrombosis. Summarize the management considerations for internal jugular vein thrombosis. Explain the importance of improving care coordination amongst interprofessional team members to improve the outcomes of patients with internal jugular vein thrombosis thrombosis. Access free multiple choice questions on this topic."}
{"id": "article-23616_2", "title": "Internal Jugular Vein Thrombosis -- Introduction", "content": "The internal jugular vein (IJV) originates at the jugular foramen, tracks down to the lateral neck and ends at the brachiocephalic vein.\u00a0The IJV is one of the four components of the carotid sheath, along with\u00a0the common carotid artery, internal carotid artery, the vagus nerve, and the deep cervical lymph nodes. It\u00a0courses medially to the sternocleidomastoid muscle at the carotid triangle. Studies have suggested significant variations in individuals, such as the IJV\u00a0is anterior, lateral or anterior and lateral to the common carotid artery in\u00a0the majority of the general population; whereas, for the remaining population, the IJV is medial to the common carotid artery. [1] IJV thrombosis is the formation of\u00a0thrombus located intraluminally in the IJV. Hereditary\u00a0and acquired risk factors for thrombosis include intravenous drug use, factor V Leiden mutation, malignancies, hormone replacement therapy, immobilization,\u00a0trauma, and pregnancy. These factors contribute to either one or more of the three components of Virchow triad: increased blood coagulation, altered blood flow (stasis) or endothelial dysfunction which lead to thrombosis. [2] The internal jugular vein is a common route\u00a0used by clinicians to access the central circulation for hemodynamical monitoring and stabilization\u00a0due to\u00a0its accessibility and anatomic location. Intravenous catheters cause injuries to the endothelium and vein wall inflammation. The most frequently encountered site of deep vein thrombosis for centrally placed catheters is the IJV. [3]", "contents": "Internal Jugular Vein Thrombosis -- Introduction. The internal jugular vein (IJV) originates at the jugular foramen, tracks down to the lateral neck and ends at the brachiocephalic vein.\u00a0The IJV is one of the four components of the carotid sheath, along with\u00a0the common carotid artery, internal carotid artery, the vagus nerve, and the deep cervical lymph nodes. It\u00a0courses medially to the sternocleidomastoid muscle at the carotid triangle. Studies have suggested significant variations in individuals, such as the IJV\u00a0is anterior, lateral or anterior and lateral to the common carotid artery in\u00a0the majority of the general population; whereas, for the remaining population, the IJV is medial to the common carotid artery. [1] IJV thrombosis is the formation of\u00a0thrombus located intraluminally in the IJV. Hereditary\u00a0and acquired risk factors for thrombosis include intravenous drug use, factor V Leiden mutation, malignancies, hormone replacement therapy, immobilization,\u00a0trauma, and pregnancy. These factors contribute to either one or more of the three components of Virchow triad: increased blood coagulation, altered blood flow (stasis) or endothelial dysfunction which lead to thrombosis. [2] The internal jugular vein is a common route\u00a0used by clinicians to access the central circulation for hemodynamical monitoring and stabilization\u00a0due to\u00a0its accessibility and anatomic location. Intravenous catheters cause injuries to the endothelium and vein wall inflammation. The most frequently encountered site of deep vein thrombosis for centrally placed catheters is the IJV. [3]"}
{"id": "article-23616_3", "title": "Internal Jugular Vein Thrombosis -- Etiology", "content": "A German physician, Rudolf Virchow is the first ever to coin the term of thrombosis and pulmonary embolism in 1855. The Virchow Triad refers to hypercoagulability,\u00a0stasis or turbulence in blood flow\u00a0and endothelial dysfunction. Despite being flushed with anticoagulants such as heparin, catheter placement in the internal jugular vein not only causes changes in the blood flow but also causes\u00a0injury to the endothelium of the vein. In a retrospective review by Major KM et al. showed that the presence of a central venous catheter was a significant factor for\u00a0IJV thrombosis. [3] However, there are various causes of the\u00a0IJV such as Inherited hypercoagulable states, including\u00a0Factor V Leiden mutation,\u00a0Protein S deficiency, Protein C deficiency, Antithrombin deficiency,\u00a0acquired risk factors including previous thromboembolism, malignancy, pregnancy, oral contraceptives, an intravenous drug, trauma, immobilization. Additionally, jugular vein suppurative thrombophlebitis, also known as Lemierre syndrome is suspected\u00a0in patients with persistent bacteremia preceded by pharyngitis, dental infections or infectious mononucleosis. There have also been reports of surgical complications to the neck, necrotizing fasciitis,\u00a0antiphospholipid syndrome, nephrotic syndrome, and severe burns.", "contents": "Internal Jugular Vein Thrombosis -- Etiology. A German physician, Rudolf Virchow is the first ever to coin the term of thrombosis and pulmonary embolism in 1855. The Virchow Triad refers to hypercoagulability,\u00a0stasis or turbulence in blood flow\u00a0and endothelial dysfunction. Despite being flushed with anticoagulants such as heparin, catheter placement in the internal jugular vein not only causes changes in the blood flow but also causes\u00a0injury to the endothelium of the vein. In a retrospective review by Major KM et al. showed that the presence of a central venous catheter was a significant factor for\u00a0IJV thrombosis. [3] However, there are various causes of the\u00a0IJV such as Inherited hypercoagulable states, including\u00a0Factor V Leiden mutation,\u00a0Protein S deficiency, Protein C deficiency, Antithrombin deficiency,\u00a0acquired risk factors including previous thromboembolism, malignancy, pregnancy, oral contraceptives, an intravenous drug, trauma, immobilization. Additionally, jugular vein suppurative thrombophlebitis, also known as Lemierre syndrome is suspected\u00a0in patients with persistent bacteremia preceded by pharyngitis, dental infections or infectious mononucleosis. There have also been reports of surgical complications to the neck, necrotizing fasciitis,\u00a0antiphospholipid syndrome, nephrotic syndrome, and severe burns."}
{"id": "article-23616_4", "title": "Internal Jugular Vein Thrombosis -- Epidemiology", "content": "A cross-section study suggested that the most common causes of internal jugular vein thrombosis are cancer and\u00a0central venous catheter. [4] A systematic review and meta-analysis revealed 7.5 percent of patients\u00a0out of\u00a05636 cancer patients developed catheter-related venous thrombosis. [5] In examining catheter-related venous thrombosis, researchers weighed many\u00a0factors such as the previous history of deep vein thrombosis, insertion site, and positioning of the catheter tip. Patients with factor V Leiden or other hypercoagulopathy were found to have a threefold increased risk of developing upper extremities thrombosis.", "contents": "Internal Jugular Vein Thrombosis -- Epidemiology. A cross-section study suggested that the most common causes of internal jugular vein thrombosis are cancer and\u00a0central venous catheter. [4] A systematic review and meta-analysis revealed 7.5 percent of patients\u00a0out of\u00a05636 cancer patients developed catheter-related venous thrombosis. [5] In examining catheter-related venous thrombosis, researchers weighed many\u00a0factors such as the previous history of deep vein thrombosis, insertion site, and positioning of the catheter tip. Patients with factor V Leiden or other hypercoagulopathy were found to have a threefold increased risk of developing upper extremities thrombosis."}
{"id": "article-23616_5", "title": "Internal Jugular Vein Thrombosis -- Pathophysiology", "content": "The pathogenesis of venous thromboembolism (VTE) is Virchow triad. Three components of Virchow triad as below, Vascular endothelial injury, such as atherosclerosis, central venous catheter placement, vascular inflammation, trauma, severe burn Change of blood flow, such as immobility, arrhythmia, venous mechanical obstruction Hypercoagulopathy, such as thrombophilia, malignancy, nephrotic syndrome, pregnancy, hormone therapy Internal jugular vein thrombosis is most commonly due to prolonged central venous catheterization, trauma to the neck, infection, ovarian hyperstimulation syndrome (OHSS) and\u00a0intravenous drug abuse.", "contents": "Internal Jugular Vein Thrombosis -- Pathophysiology. The pathogenesis of venous thromboembolism (VTE) is Virchow triad. Three components of Virchow triad as below, Vascular endothelial injury, such as atherosclerosis, central venous catheter placement, vascular inflammation, trauma, severe burn Change of blood flow, such as immobility, arrhythmia, venous mechanical obstruction Hypercoagulopathy, such as thrombophilia, malignancy, nephrotic syndrome, pregnancy, hormone therapy Internal jugular vein thrombosis is most commonly due to prolonged central venous catheterization, trauma to the neck, infection, ovarian hyperstimulation syndrome (OHSS) and\u00a0intravenous drug abuse."}
{"id": "article-23616_6", "title": "Internal Jugular Vein Thrombosis -- History and Physical", "content": "Internal jugular vein thrombosis\u00a0is asymptomatic in the majority of patients. Due to its subtle manifestation, it is difficult to diagnose for clinicians. However, patients may present with typical signs for deep vein thrombosis such as erythema, tenderness, and warmth. On physical examination,\u00a0swelling at the left sided neck, mandible angle or the anterior border of the sternocleidomastoid muscle can be found. Internal jugular vein thrombosis in the setting of infection as known as Lemierre syndrome (necrobacillosis), fever, headache, swelling of the neck and angle of the jaw along with trismus is another possible presentation.", "contents": "Internal Jugular Vein Thrombosis -- History and Physical. Internal jugular vein thrombosis\u00a0is asymptomatic in the majority of patients. Due to its subtle manifestation, it is difficult to diagnose for clinicians. However, patients may present with typical signs for deep vein thrombosis such as erythema, tenderness, and warmth. On physical examination,\u00a0swelling at the left sided neck, mandible angle or the anterior border of the sternocleidomastoid muscle can be found. Internal jugular vein thrombosis in the setting of infection as known as Lemierre syndrome (necrobacillosis), fever, headache, swelling of the neck and angle of the jaw along with trismus is another possible presentation."}
{"id": "article-23616_7", "title": "Internal Jugular Vein Thrombosis -- Evaluation", "content": "Laboratory studies may\u00a0show an increased level of D-dimer,\u00a0a degradation product of fibrin that is highly sensitive and nonspecific\u00a0for venous thrombosis. Elevated levels of D-dimer present in malignancy, sepsis, recent surgery or trauma, pregnancy which often coexist with internal jugular vein thrombosis. Compression ultrasonography with Doppler is the test of choice for diagnosis with a\u00a0sensitivity of 96% and a specificity of 93%. [6] While venography\u00a0is the gold standard for diagnosing the\u00a0IJV thrombosis, bedside ultrasound is noninvasive and rapid which may show hyperechoic thrombus within the IJV. CT scan may indicate\u00a0an intraluminal filling defect in the jugular venous wall. CT scan\u00a0may be superior to ultrasound due to a better assessment of veins located under soft tissues.", "contents": "Internal Jugular Vein Thrombosis -- Evaluation. Laboratory studies may\u00a0show an increased level of D-dimer,\u00a0a degradation product of fibrin that is highly sensitive and nonspecific\u00a0for venous thrombosis. Elevated levels of D-dimer present in malignancy, sepsis, recent surgery or trauma, pregnancy which often coexist with internal jugular vein thrombosis. Compression ultrasonography with Doppler is the test of choice for diagnosis with a\u00a0sensitivity of 96% and a specificity of 93%. [6] While venography\u00a0is the gold standard for diagnosing the\u00a0IJV thrombosis, bedside ultrasound is noninvasive and rapid which may show hyperechoic thrombus within the IJV. CT scan may indicate\u00a0an intraluminal filling defect in the jugular venous wall. CT scan\u00a0may be superior to ultrasound due to a better assessment of veins located under soft tissues."}
{"id": "article-23616_8", "title": "Internal Jugular Vein Thrombosis -- Treatment / Management", "content": "The risk of bleeding requires careful assessment. Anticoagulation therapy is individualized for each patient; tools such as HAS-BLED help assess the bleeding risk\u00a0in adults [7] However, no definitive index or tool can reliably predict bleeding risk in patients with internal jugular vein thrombosis. In patients with an\u00a0indwelling catheter, it is crucial to remove the catheter; however, if the catheter cannot be removed for any reason, then anticoagulants should be initiated. Patients without bleeding risks should receive dual therapy with low molecular weight (LMW) heparin and warfarin, dual therapy with LMW heparin followed by direct thrombin inhibitor or factor Xa inhibitor, or monotherapy with\u00a0factor Xa inhibitor. For high-risk patients like thrombophilia, some studies have suggested an INR maintained between 2.5 and 3.0; long-term warfarin therapy can also be a consideration.\u00a0However, clinical studies in anticoagulation therapy for\u00a0IJV thrombosis are lacking.\u00a0Internal jugular vein thrombosis is often found incidentally in the majority of the patients. Hence, many patients were left untreated.\u00a0Intravenous thrombolytic infusion regimens such as alteplase have been reported to be effective in\u00a0IJV thrombosis. For patients diagnosed with catheter-induced\u00a0IJV thrombosis, thrombolysis is not recommended as first-line therapy, as there is sparse evidence to suggest that thrombolysis leads to better outcomes than anticoagulation. Rarely do patients need surgical interventions.", "contents": "Internal Jugular Vein Thrombosis -- Treatment / Management. The risk of bleeding requires careful assessment. Anticoagulation therapy is individualized for each patient; tools such as HAS-BLED help assess the bleeding risk\u00a0in adults [7] However, no definitive index or tool can reliably predict bleeding risk in patients with internal jugular vein thrombosis. In patients with an\u00a0indwelling catheter, it is crucial to remove the catheter; however, if the catheter cannot be removed for any reason, then anticoagulants should be initiated. Patients without bleeding risks should receive dual therapy with low molecular weight (LMW) heparin and warfarin, dual therapy with LMW heparin followed by direct thrombin inhibitor or factor Xa inhibitor, or monotherapy with\u00a0factor Xa inhibitor. For high-risk patients like thrombophilia, some studies have suggested an INR maintained between 2.5 and 3.0; long-term warfarin therapy can also be a consideration.\u00a0However, clinical studies in anticoagulation therapy for\u00a0IJV thrombosis are lacking.\u00a0Internal jugular vein thrombosis is often found incidentally in the majority of the patients. Hence, many patients were left untreated.\u00a0Intravenous thrombolytic infusion regimens such as alteplase have been reported to be effective in\u00a0IJV thrombosis. For patients diagnosed with catheter-induced\u00a0IJV thrombosis, thrombolysis is not recommended as first-line therapy, as there is sparse evidence to suggest that thrombolysis leads to better outcomes than anticoagulation. Rarely do patients need surgical interventions."}
{"id": "article-23616_9", "title": "Internal Jugular Vein Thrombosis -- Differential Diagnosis", "content": "The clinical manifestations that accompany internal jugular vein thrombosis include erythema, swelling, and warmth along the sternocleidomastoid muscle resemble neck infections such as cellulitis. Facial pain, neck edema, a palpable cord, and neck fullness can present in some patients and may be similar to superior vena cava syndrome. A mechanical obstruction such as a lung tumor should be ruled out. Mediastinitis Superior vena cava syndrome Malignancy", "contents": "Internal Jugular Vein Thrombosis -- Differential Diagnosis. The clinical manifestations that accompany internal jugular vein thrombosis include erythema, swelling, and warmth along the sternocleidomastoid muscle resemble neck infections such as cellulitis. Facial pain, neck edema, a palpable cord, and neck fullness can present in some patients and may be similar to superior vena cava syndrome. A mechanical obstruction such as a lung tumor should be ruled out. Mediastinitis Superior vena cava syndrome Malignancy"}
{"id": "article-23616_10", "title": "Internal Jugular Vein Thrombosis -- Prognosis", "content": "In a prospective study, the mortality rate of internal jugular vein thrombosis was reported to be 44%. The mortality rate is significantly higher in patients over 75 years old, patients not treated with anticoagulation\u00a0and\u00a0patients with an indwelling central venous line.\u00a0\u00a0In patients with underlying comorbidities such as malignancy, chronic kidney diseases, infections, and multiorgan failure, mortality is significantly higher.", "contents": "Internal Jugular Vein Thrombosis -- Prognosis. In a prospective study, the mortality rate of internal jugular vein thrombosis was reported to be 44%. The mortality rate is significantly higher in patients over 75 years old, patients not treated with anticoagulation\u00a0and\u00a0patients with an indwelling central venous line.\u00a0\u00a0In patients with underlying comorbidities such as malignancy, chronic kidney diseases, infections, and multiorgan failure, mortality is significantly higher."}
{"id": "article-23616_11", "title": "Internal Jugular Vein Thrombosis -- Complications", "content": "Pulmonary embolism is the most common\u00a0complications in upper extremity thrombosis, followed by post-thrombotic syndrome and death. [8] Complications of\u00a0IJV thrombosis are pulmonary embolism (10.3%) and post-thrombotic syndrome (41.4%). [4] In Lemierre's syndrome, without proper antibiotic management, 97 percent of cases developed septic emboli to the lung. [9]", "contents": "Internal Jugular Vein Thrombosis -- Complications. Pulmonary embolism is the most common\u00a0complications in upper extremity thrombosis, followed by post-thrombotic syndrome and death. [8] Complications of\u00a0IJV thrombosis are pulmonary embolism (10.3%) and post-thrombotic syndrome (41.4%). [4] In Lemierre's syndrome, without proper antibiotic management, 97 percent of cases developed septic emboli to the lung. [9]"}
{"id": "article-23616_12", "title": "Internal Jugular Vein Thrombosis -- Deterrence and Patient Education", "content": "Internal jugular vein thrombosis is asymptomatic in most patients. Clinicians should carefully evaluate swelling, erythema, or tenderness in the angle of the jaw or the side of the neck. Complications such as pulmonary embolism although rare but can occur. Further\u00a0investigations on malignancy, hypercoagulopathy or infections are necessary for recurrence prevention.\u00a0Anticoagulation therapy is the treatment of choice for patients without contraindications.", "contents": "Internal Jugular Vein Thrombosis -- Deterrence and Patient Education. Internal jugular vein thrombosis is asymptomatic in most patients. Clinicians should carefully evaluate swelling, erythema, or tenderness in the angle of the jaw or the side of the neck. Complications such as pulmonary embolism although rare but can occur. Further\u00a0investigations on malignancy, hypercoagulopathy or infections are necessary for recurrence prevention.\u00a0Anticoagulation therapy is the treatment of choice for patients without contraindications."}
{"id": "article-23616_13", "title": "Internal Jugular Vein Thrombosis -- Pearls and Other Issues", "content": "Internal jugular vein thrombosis has been reported to be more common due to the widespread use of the internal jugular vein for venous access, central venous catheters. Of note, an increased number of IV drug abuses present with IJV thrombosis, nevertheless anticoagulation still is the mainstay of treatment comparing to thrombolysis or surgical intervention.", "contents": "Internal Jugular Vein Thrombosis -- Pearls and Other Issues. Internal jugular vein thrombosis has been reported to be more common due to the widespread use of the internal jugular vein for venous access, central venous catheters. Of note, an increased number of IV drug abuses present with IJV thrombosis, nevertheless anticoagulation still is the mainstay of treatment comparing to thrombolysis or surgical intervention."}
{"id": "article-23616_14", "title": "Internal Jugular Vein Thrombosis -- Enhancing Healthcare Team Outcomes", "content": "Anticoagulation is the treatment of choice for patients with internal jugular vein thrombosis. [10] [Level l] Anticoagulant therapy following a diagnosis of\u00a0IJV thrombosis\u00a0prevents severe complications such as pulmonary embolism. The pharmacist, nurse practitioner, internist or the primary care provider can monitor the patient's anticoagulation status. These professionals need to work together in an interprofessional team approach to managing IJV thrombosis to ensure optimal clinical results for patients.", "contents": "Internal Jugular Vein Thrombosis -- Enhancing Healthcare Team Outcomes. Anticoagulation is the treatment of choice for patients with internal jugular vein thrombosis. [10] [Level l] Anticoagulant therapy following a diagnosis of\u00a0IJV thrombosis\u00a0prevents severe complications such as pulmonary embolism. The pharmacist, nurse practitioner, internist or the primary care provider can monitor the patient's anticoagulation status. These professionals need to work together in an interprofessional team approach to managing IJV thrombosis to ensure optimal clinical results for patients."}
{"id": "article-23616_15", "title": "Internal Jugular Vein Thrombosis -- Enhancing Healthcare Team Outcomes", "content": "In patients with asymptomatic\u00a0IJV thrombosis, anticoagulation is the recommendation, as a delay in therapy increases the risk of potentially life-threatening embolization. Anticoagulants include subcutaneous low molecular weight (LMW) heparin, subcutaneous fondaparinux, the oral factor Xa inhibitors (rivaroxaban or apixaban), or unfractionated heparin (UFH) (Level III). Anticoagulation management requires individualized customization along with clinician experience. Thus, a pharmacist should be heavily involved with agent selection with the prescriber, interaction checking, monitoring, and patient counseling. The duration of anticoagulation ranges from 4 to 12 weeks. It is standard to obtain an imaging study before discontinuing anticoagulation.", "contents": "Internal Jugular Vein Thrombosis -- Enhancing Healthcare Team Outcomes. In patients with asymptomatic\u00a0IJV thrombosis, anticoagulation is the recommendation, as a delay in therapy increases the risk of potentially life-threatening embolization. Anticoagulants include subcutaneous low molecular weight (LMW) heparin, subcutaneous fondaparinux, the oral factor Xa inhibitors (rivaroxaban or apixaban), or unfractionated heparin (UFH) (Level III). Anticoagulation management requires individualized customization along with clinician experience. Thus, a pharmacist should be heavily involved with agent selection with the prescriber, interaction checking, monitoring, and patient counseling. The duration of anticoagulation ranges from 4 to 12 weeks. It is standard to obtain an imaging study before discontinuing anticoagulation."}
{"id": "article-23616_16", "title": "Internal Jugular Vein Thrombosis -- Enhancing Healthcare Team Outcomes", "content": "The pharmacist should assist with medication selection, dosing, and management. The specialty-trained nurse should assist with patient education, coordinating follow up, and patient education. an interprofessional team approach will result in the best outcomes. [Leve 5]", "contents": "Internal Jugular Vein Thrombosis -- Enhancing Healthcare Team Outcomes. The pharmacist should assist with medication selection, dosing, and management. The specialty-trained nurse should assist with patient education, coordinating follow up, and patient education. an interprofessional team approach will result in the best outcomes. [Leve 5]"}
{"id": "article-23616_17", "title": "Internal Jugular Vein Thrombosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Internal Jugular Vein Thrombosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}